Ginsenoside Ameliorates Cognitive Dysfunction in Type 2 Diabetic Goto-Kakizaki Rats
Authors:
- 10 June 2018
- journal article
- research article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 24, 3922-3928
Abstract
BACKGROUND:Ginsenoside is the major bioactive component of ginseng, which has been proven to be a neuroprotective drug. The aim of this study was to evaluate the therapeutic effect of ginsenoside in a diabetic Goto-Kakizaki (GK) rat model. MATERIAL A...Keywords
This publication has 28 references indexed in Scilit:
- Association of Depression With Increased Risk of Dementia in Patients With Type 2 DiabetesArchives of General Psychiatry, 2012
- Ginsenosides from American ginseng: Chemical and pharmacological diversityPhytochemistry, 2011
- The mitochondrial pathway is involved in American ginseng-induced apoptosis of SW-480 colon cancer cellsOncology Reports, 2009
- Cognitive Impairment: An Increasingly Important Complication of Type 2 Diabetes: The Age, Gene/Environment Susceptibility-Reykjavik StudyAmerican Journal of Epidemiology, 2008
- Diabetes and other vascular risk factors for dementia: Which factor matters most? A systematic reviewEuropean Journal of Pharmacology, 2008
- Adiposity, hyperinsulinemia, diabetes and Alzheimer's diseaseEuropean Journal of Pharmacology, 2008
- Red American Ginseng: Ginsenoside Constituents and Antiproliferative Activities of Heat-Processed Panax quinquefolius RootsPlanta Medica, 2007
- Morris water maze: procedures for assessing spatial and related forms of learning and memoryNature Protocols, 2006
- Anti-hyperglycemic effects of ginseng: Comparison between root and berryPhytomedicine, 2003
- Ginseng berry reduces blood glucose and body weight in db/db micePhytomedicine, 2002